Acadian Asset Management’s Castle Biosciences CSTL Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $11.1M | Sell |
544,250
-131,816
| -19% | -$2.69M | 0.02% | 413 |
|
|
2025
Q1 | $13.5M | Buy |
676,066
+267,416
| +65% | +$5.35M | 0.04% | 279 |
|
|
2024
Q4 | $10.9M | Buy |
408,650
+7,412
| +2% | +$197K | 0.03% | 336 |
|
|
2024
Q3 | $11.4M | Buy |
401,238
+120,741
| +43% | +$3.44M | 0.04% | 320 |
|
|
2024
Q2 | $6.1M | Buy |
280,497
+69,673
| +33% | +$1.52M | 0.02% | 455 |
|
|
2024
Q1 | $4.67M | Buy |
210,824
+119,443
| +131% | +$2.65M | 0.02% | 486 |
|
|
2023
Q4 | $1.97M | Buy |
+91,381
| New | +$1.97M | 0.01% | 675 |
|
|
2021
Q1 | – | Sell |
-5,315
| Closed | -$357K | – | 2101 |
|
|
2020
Q4 | $357K | Sell |
5,315
-61,458
| -92% | -$4.13M | ﹤0.01% | 1342 |
|
|
2020
Q3 | $3.44M | Buy |
66,773
+27,911
| +72% | +$1.44M | 0.01% | 519 |
|
|
2020
Q2 | $1.47M | Buy |
38,862
+30,297
| +354% | +$1.14M | 0.01% | 828 |
|
|
2020
Q1 | $255K | Buy |
+8,565
| New | +$255K | ﹤0.01% | 1140 |
|